These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 20523363

  • 1. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
    Germano IM, Emdad L, Qadeer ZA, Binello E, Uzzaman M.
    Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
    [Abstract] [Full Text] [Related]

  • 2. Gene expression profiling predicts response to temozolomide in malignant gliomas.
    Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K.
    Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
    [Abstract] [Full Text] [Related]

  • 3. A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.
    Ziegler DS, Keating J, Kesari S, Fast EM, Zawel L, Ramakrishna N, Barnes J, Kieran MW, Veldhuijzen van Zanten SE, Kung AL.
    Neuro Oncol; 2011 Aug; 13(8):820-9. PubMed ID: 21724651
    [Abstract] [Full Text] [Related]

  • 4. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas.
    Soritau O, Tomuleasa C, Aldea M, Petrushev B, Susman S, Gheban D, Ioani H, Cosis A, Brie I, Irimie A, Kacso G, Florian IS.
    J BUON; 2011 Aug; 16(2):282-9. PubMed ID: 21766499
    [Abstract] [Full Text] [Related]

  • 5. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
    Uzzaman M, Keller G, Germano IM.
    Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
    [Abstract] [Full Text] [Related]

  • 6. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS.
    Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
    [Abstract] [Full Text] [Related]

  • 7. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
    Short SC, Giampieri S, Worku M, Alcaide-German M, Sioftanos G, Bourne S, Lio KI, Shaked-Rabi M, Martindale C.
    Neuro Oncol; 2011 May; 13(5):487-99. PubMed ID: 21363882
    [Abstract] [Full Text] [Related]

  • 8. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F, Rynkowski M, DeWitte O, Kiss R.
    Adv Tech Stand Neurosurg; 2009 May; 34():3-35. PubMed ID: 19368079
    [Abstract] [Full Text] [Related]

  • 9. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

  • 10. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS.
    Br J Cancer; 2009 Apr 07; 100(7):1154-64. PubMed ID: 19277041
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM, Wang CY, Liaw HJ, Fang KM, Yang CS, Tzeng SF.
    Oncotarget; 2014 Nov 15; 5(21):10901-15. PubMed ID: 25337721
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside.
    Germano IM, Binello E.
    J Neurooncol; 2009 May 15; 93(1):79-87. PubMed ID: 19430884
    [Abstract] [Full Text] [Related]

  • 13. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
    Koukourakis GV, Kouloulias V, Zacharias G, Papadimitriou C, Pantelakos P, Maravelis G, Fotineas A, Beli I, Chaldeopoulos D, Kouvaris J.
    Molecules; 2009 Apr 16; 14(4):1561-77. PubMed ID: 19384285
    [Abstract] [Full Text] [Related]

  • 14. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
    Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA.
    Cancer Gene Ther; 2009 Oct 16; 16(10):794-805. PubMed ID: 19363468
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
    Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.
    J Cancer Res Clin Oncol; 2015 Jan 16; 141(1):75-85. PubMed ID: 25103017
    [Abstract] [Full Text] [Related]

  • 16. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
    Hingtgen S, Ren X, Terwilliger E, Classon M, Weissleder R, Shah K.
    Mol Cancer Ther; 2008 Nov 16; 7(11):3575-85. PubMed ID: 19001440
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
    Sauvageot CM, Weatherbee JL, Kesari S, Winters SE, Barnes J, Dellagatta J, Ramakrishna NR, Stiles CD, Kung AL, Kieran MW, Wen PY.
    Neuro Oncol; 2009 Apr 16; 11(2):109-21. PubMed ID: 18682579
    [Abstract] [Full Text] [Related]

  • 18. Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas.
    Chaponis D, Barnes JW, Dellagatta JL, Kesari S, Fast E, Sauvageot C, Panagrahy D, Greene ER, Ramakrishna N, Wen PY, Kung AL, Stiles C, Kieran MW.
    J Neurooncol; 2011 Aug 16; 104(1):179-89. PubMed ID: 21246394
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I, Sperling S, Kim E, Schulz-Schaeffer W, Rave-Fränk M, Hasselblatt M, Jelkmann W, Giese A, Ehrenreich H.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):927-34. PubMed ID: 19014782
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.
    Health Technol Assess; 2007 Nov 01; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.